Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sadeer Alzubaidi

Diagnostic Radiology Scottsdale, AZ Medical Doctor

NPI 1609048578 CMS profile 1006832

13400 E Shea Blvd, Scottsdale, AZ 85259

Open in the dashboard

General payments

$53,516

192 records reported · program years 2019–2025

Research payments

$1,848

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sadeer Alzubaidi of Scottsdale, AZ is reported in the CMS Open Payments database as having received $53,516 across 192 general payments and $1,848 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $20,061 65
2025 Research $1,848 1
2024 General $13,853 40
2023 General $6,984 38
2022 General $1,687 13
2021 General $830 10
2020 General $2,038 9
2019 General $8,063 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sadeer Alzubaidi
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Sadeer Alzubaidi were reported at $20,061. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Sadeer Alzubaidi Diagnostic Radiology median Middle half National median
2019 $8,063 $108 $29–$318 $163
2020 $2,038 $65 $21–$252 $114
2021 $830 $92 $24–$292 $132
2022 $1,687 $104 $29–$294 $149
2023 $6,984 $110 $29–$337 $160
2024 $13,853 $113 $30–$356 $164
2025 $20,061 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $19,422 50 payments
  2. Penumbra, Inc. $15,548 51 payments
  3. Biocompatibles, Inc. $7,125 6 payments
  4. AstraZeneca Pharmaceuticals LP $3,257 3 payments
  5. Siemens Medical Solutions USA, Inc. $1,617 19 payments
  6. Cook Medical LLC $865 10 payments
  7. Inari Medical, Inc. $646 4 payments
  8. Terumo Medical Corporation $603 3 payments
  9. Argon Medical Devices, Inc. $538 3 payments
  10. Medtronic, Inc. $473 6 payments
  11. Other $3,423 37 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $19,950 9 payments
  2. Food and Beverage $14,420 150 payments
  3. Consulting Fee $10,685 6 payments
  4. Travel and Lodging $8,443 26 payments
  5. Education $18 1 payment
Products named General payments · program years 2019–2025
  1. TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) $15,385 13 payments
  2. Indigo System $15,159 46 payments
  3. THERASPHERE - BIO Interventional Oncology $6,708 3 payments
  4. IMFINZI $3,222 2 payments
  5. TheraSphere Y90 Glass Microspheres 10 GBq $822 9 payments
  6. THERASPHERE - BIO Interventional Oncology $713 1 payment
  7. MicroThermX Microwave Ablation System $525 3 payments
  8. CT THROMBECTOMY SYSTEM KIT $496 3 payments
  9. FLOWTRIEVER CATHETER, S $496 3 payments
  10. GENERAL - EMBOLICS $453 4 payments
  11. Other $7,988 88 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $1,848 1 payment

Billing to Medicare

Part B · data year 2024 · 113 billing codes

Paid by Medicare

$97,600

Of which drugs: $339

Medicare patients

388

Average age 74

Services billed

4,389

144 women, 244 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 52%
Chronic kidney disease 48%
Ischemic heart disease 42%
Cancer 38%
Diabetes 33%
Atrial fibrillation 29%
Depression 29%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 24 3,262 $339

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
IMFINZI
  • AstraZeneca Pharmaceuticals LP $1,880
$1,880 — —
KEYTRUDA
  • Merck Sharp & Dohme Corporation $18
$18 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

193 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record